Alternative lengthening of telomeres: models, mechanisms and implications (original) (raw)
Olovnikov, A. M. A theory of marginotomy. The incomplete copying of template margin in enzymic synthesis of polynucleotides and biological significance of the phenomenon. J. Theor. Biol.41, 181–190 (1973). CASPubMed Google Scholar
Watson, J. D. Origin of concatemeric T7 DNA. Nature New Biol.239, 197–201 (1972). CASPubMed Google Scholar
d'Adda di Fagagna, F. et al. A DNA damage checkpoint response in telomere-initiated senescence. Nature426, 194–198 (2003). CASPubMed Google Scholar
Harley, C. B., Futcher, A. B. & Greider, C. W. Telomeres shorten during ageing of human fibroblasts. Nature345, 458–460 (1990). CASPubMed Google Scholar
Blackburn, E. H., Greider, C. W. & Szostak, J. W. Telomeres and telomerase: the path from maize, Tetrahymena and yeast to human cancer and aging. Nature Med.12, 1133–1138 (2006). CASPubMed Google Scholar
Makarov, V. L., Hirose, Y. & Langmore, J. P. Long G tails at both ends of human chromosomes suggest a C strand degradation mechanism for telomere shortening. Cell88, 657–666 (1997). CASPubMed Google Scholar
Griffith, J. D. et al. Mammalian telomeres end in a large duplex loop. Cell97, 503–514 (1999). CASPubMed Google Scholar
Palm, W. & de Lange, T. How shelterin protects mammalian telomeres. Annu. Rev. Genet.42, 301–334 (2008). A comprehensive review of the six-protein shelterin complex that is crucially important for telomere functions. CASPubMed Google Scholar
Reddel, R. R. The role of senescence and immortalization in carcinogenesis. Carcinogenesis21, 477–484 (2000). CASPubMed Google Scholar
Shay, J. W. & Bacchetti, S. A survey of telomerase activity in human cancer. Eur. J. Cancer33, 787–791 (1997). CASPubMed Google Scholar
Bryan, T. M., Englezou, A., Dalla-Pozza, L., Dunham, M. A. & Reddel, R. R. Evidence for an alternative mechanism for maintaining telomere length in human tumors and tumor-derived cell lines. Nature Med.3, 1271–1274 (1997). CASPubMed Google Scholar
Hakin-Smith, V. et al. Alternative lengthening of telomeres and survival in patients with glioblastoma multiforme. Lancet361, 836–838 (2003). CASPubMed Google Scholar
Henson, J. D. et al. A robust assay for alternative lengthening of telomeres (ALT) in tumors demonstrates the significance of ALT in sarcomas and astrocytomas. Clin. Cancer Res.11, 217–225 (2005). CASPubMed Google Scholar
Costa, A. et al. Telomere maintenance mechanisms in liposarcomas: association with histologic subtypes and disease progression. Cancer Res.66, 8918–8924 (2006). CASPubMed Google Scholar
Villa, R. et al. Multiple mechanisms of telomere maintenance exist and differentially affect clinical outcome in diffuse malignant peritoneal mesothelioma. Clin. Cancer Res.14, 4134–4140 (2008). CASPubMed Google Scholar
Subhawong, A. P. et al. The alternative lengthening of telomeres phenotype in breast carcinoma is associated with HER-2 overexpression. Mod. Pathol.22, 1423–1431 (2009). CASPubMed Google Scholar
Jeyapalan, J. N., Mendez-Bermudez, A., Zaffaroni, N., Dubrova, Y. E. & Royle, N. J. Evidence for alternative lengthening of telomeres in liposarcomas in the absence of ALT-associated PML bodies. Int. J. Cancer122, 2414–2421 (2008). CASPubMed Google Scholar
Lafferty-Whyte, K. et al. A gene expression signature classifying telomerase and ALT immortalization reveals an hTERT regulatory network and suggests a mesenchymal stem cell origin for ALT. Oncogene28, 3765–3774 (2009). CASPubMedPubMed Central Google Scholar
Cesare, A. J. & Griffith, J. D. Telomeric DNA in ALT cells is characterized by free telomeric circles and heterogeneous t-loops. Mol. Cell. Biol.24, 9948–9957 (2004). CASPubMedPubMed Central Google Scholar
Wang, R. C., Smogorzewska, A. & de Lange, T. Homologous recombination generates t-loop-sized deletions at human telomeres. Cell119, 355–368 (2004). CASPubMed Google Scholar
Nabetani, A. & Ishikawa, F. Unusual telomeric DNAs in human telomerase-negative immortalized cells. Mol. Cell. Biol.29, 703–713 (2009). The authors performed a detailed analysis of the various forms of extrachromosomal telomeric DNA present in ALT cells. CASPubMed Google Scholar
Henson, J. D. et al. DNA C-circles are specific and quantifable markers of alternative-lengthening-of-telomeres activity. Nature Biotech.27, 1181–1185 (2009). The abundance of partially single-stranded circles of telomeric DNA in which the C-rich strand is essentially intact (C-circles) correlates with the amount of ALT activity in cells. Levels of C-circles fall rapidly after inhibition of ALT activity, and are therefore rapidly responsive to changes in ALT activity. CAS Google Scholar
Tokutake, Y. et al. Extra-chromosome telomere repeat DNA in telomerase-negative immortalized cell lines. Biochem. Biophys. Res. Commun.247, 765–772 (1998). CASPubMed Google Scholar
Ogino, H. et al. Release of telomeric DNA from chromosomes in immortal human cells lacking telomerase activity. Biochem. Biophys. Res. Commun.248, 223–227 (1998). CASPubMed Google Scholar
Yeager, T. R. et al. Telomerase-negative immortalized human cells contain a novel type of promyelocytic leukemia (PML) body. Cancer Res.59, 4175–4179 (1999). CASPubMed Google Scholar
Bryan, T. M., Englezou, A., Gupta, J., Bacchetti, S. & Reddel, R. R. Telomere elongation in immortal human cells without detectable telomerase activity. EMBO J.14, 4240–4248 (1995). This study showed that telomere lengths are maintained by an alternative mechanism in immortalized, telomerase-negative human cells. CASPubMedPubMed Central Google Scholar
Murnane, J. P., Sabatier, L., Marder, B. A. & Morgan, W. F. Telomere dynamics in an immortal human cell line. EMBO J.13, 4953–4962 (1994). The authors showed that the telomeres of telomerase-negative human cells can undergo rapid shortening and lengthening events, and deduced that these events are likely to result from recombination. CASPubMedPubMed Central Google Scholar
Perrem, K., Colgin, L. M., Neumann, A. A., Yeager, T. R. & Reddel, R. R. Coexistence of alternative lengthening of telomeres and telomerase in hTERT-transfected GM847 cells. Mol. Cell. Biol.21, 3862–3875 (2001). CASPubMedPubMed Central Google Scholar
Londono-Vallejo, J. A., Der-Sarkissian, H., Cazes, L., Bacchetti, S. & Reddel, R. R. Alternative lengthening of telomeres is characterized by high rates of telomeric exchange. Cancer Res.64, 2324–2327 (2004). CASPubMed Google Scholar
Tomaska, L., Nosek, J., Kramara, J. & Griffith, J. D. Telomeric circles: universal players in telomere maintenance? Nature Struct. Mol. Biol.16, 1010–1015 (2009). CAS Google Scholar
Compton, S. A., Choi, J. H., Cesare, A. J., Ozgur, S. & Griffith, J. D. Xrcc3 and Nbs1 are required for the production of extrachromosomal telomeric circles in human alternative lengthening of telomere cells. Cancer Res.67, 1513–1519 (2007). CASPubMed Google Scholar
Cesare, A. J., Groff-Vindman, C., Compton, S. A., McEachern, M. J. & Griffith, J. D. Telomere loops and homologous recombination-dependent telomeric circles in a Kluyveromyces lactis telomere mutant strain. Mol. Cell. Biol.28, 20–29 (2008). CASPubMed Google Scholar
Pickett, H. A., Cesare, A. J., Johnstone, R. L., Neumann, A. A. & Reddel, R. R. Control of telomere length by a trimming mechanism that involves generation of t-circles. EMBO J.28, 799–809 (2009). CASPubMedPubMed Central Google Scholar
Li, B. & Lustig, A. J. A novel mechanism for telomere size control in Saccharomyces cerevisiae. Genes Dev.10, 1310–1326 (1996). CASPubMed Google Scholar
Lundblad, V. & Blackburn, E. H. An alternative pathway for yeast telomere maintenance rescues _est1_− senescence. Cell73, 347–360 (1993). This paper described telomerase-null survivor yeast and provided genetic evidence that the survivors depend on homologous recombination. CASPubMed Google Scholar
Rogan, E. M. et al. Alterations in p53 and p16_INK4_ expression and telomere length during spontaneous immortalization of Li-Fraumeni syndrome fibroblasts. Mol. Cell. Biol.15, 4745–4753 (1995). CASPubMedPubMed Central Google Scholar
Dunham, M. A., Neumann, A. A., Fasching, C. L. & Reddel, R. R. Telomere maintenance by recombination in human cells. Nature Genet.26, 447–450 (2000). A DNA tag inserted into telomeres by targeting was copied to other telomeres in ALT cells, but not telomerase-positive cells, consistent with the hypothesis that telomeres may be elongated in ALT cells by replicating the sequence of other telomeres. CASPubMed Google Scholar
Varley, H., Pickett, H. A., Foxon, J. L., Reddel, R. R. & Royle, N. J. Molecular characterization of inter-telomere and intra-telomere mutations in human ALT cells. Nature Genet.30, 301–305 (2002). Analysis of DNA repeat sequences in telomeres of ALT cells showed complex rearrangements that are most simply explained by recombination between non-sister telomeres or between telomeres and extrachromosomal telomeric DNA. PubMed Google Scholar
Bechter, O. E., Zou, Y., Walker, W., Wright, W. E. & Shay, J. W. Telomeric recombination in mismatch repair deficient human colon cancer cells after telomerase inhibition. Cancer Res.64, 3444–3451 (2004). CASPubMed Google Scholar
Bechter, O. E., Shay, J. W. & Wright, W. E. The frequency of homologous recombination in human ALT cells. Cell Cycle3, 547–549 (2004). CASPubMed Google Scholar
Tsutsui, T. et al. Immortal, telomerase-negative cell lines derived from a Li-Fraumeni syndrome patient exhibit telomere length variability and chromosomal and minisatellite instabilities. Carcinogenesis24, 953–965 (2003). CASPubMed Google Scholar
Jeyapalan, J. N. et al. Activation of the ALT pathway for telomere maintenance can affect other sequences in the human genome. Hum. Mol. Genet.14, 1785–1794 (2005). CASPubMed Google Scholar
Wilson, D. M. & Thompson, L. H. Molecular mechanisms of sister-chromatid exchange. Mutat. Res.616, 11–23 (2007). CASPubMed Google Scholar
Bailey, S. M., Brenneman, M. A. & Goodwin, E. H. Frequent recombination in telomeric DNA may extend the proliferative life of telomerase-negative cells. Nucleic Acids Res.32, 3743–3751 (2004). CASPubMedPubMed Central Google Scholar
Muntoni, A. & Reddel, R. R. The first molecular details of ALT in human tumor cells. Hum. Mol. Genet.14, R191–R196 (2005). CASPubMed Google Scholar
Blagoev, K. B. & Goodwin, E. H. Telomere exchange and asymmetric segregation of chromosomes can account for the unlimited proliferative potential of ALT cell populations. DNA Repair (Amst.)7, 199–204 (2008). The authors provided a mathematical model showing that telomere lengths can be maintained in a cell population by a combination of unequal telomeric sister chromatid exchange and a putative mechanism for segregating the lengthened telomeres into one of the daughter cells. CAS Google Scholar
Falconer, E. et al. Identification of sister chromatids by DNA template strand sequences. Nature463, 93–97 (2010). CASPubMed Google Scholar
Henson, J. D., Neumann, A. A., Yeager, T. R. & Reddel, R. R. Alternative lengthening of telomeres in mammalian cells. Oncogene21, 598–610 (2002). CASPubMed Google Scholar
Muntoni, A., Neumann, A. A., Hills, M. & Reddel, R. R. Telomere elongation involves intra-molecular DNA replication in cells utilizing alternative lengthening of telomeres. Hum. Mol. Genet.18, 1017–1027 (2009). CASPubMed Google Scholar
Jiang, W. Q. et al. Suppression of alternative lengthening of telomeres by Sp100-mediated sequestration of MRE11/RAD50/NBS1 complex. Mol. Cell. Biol.25, 2708–2721 (2005). The authors found that overexpression of exogenous SP100 can inhibit ALT activity and cause progressive telomere shortening, and provided evidence that this results from sequestration of the MRN HR-protein complex away from telomeres. CASPubMedPubMed Central Google Scholar
Zhong, Z. H. et al. Disruption of telomere maintenance by depletion of the MRE11/RAD50/NBS1 complex in cells that use alternative lengthening of telomeres. J. Biol. Chem.282, 29314–29322 (2007). CASPubMed Google Scholar
Lee, J. H. & Paull, T. T. Activation and regulation of ATM kinase activity in response to DNA double-strand breaks. Oncogene26, 7741–7748 (2007). CASPubMed Google Scholar
Zhu, X. D., Kuster, B., Mann, M., Petrini, J. H. & de Lange, T. Cell-cycle-regulated association of RAD50/MRE11/NBS1 with TRF2 and human telomeres. Nature Genet.25, 347–352 (2000). CASPubMed Google Scholar
Deng, Y., Guo, X., Ferguson, D. O. & Chang, S. Multiple roles for MRE11 at uncapped telomeres. Nature460, 914–919 (2009). CASPubMedPubMed Central Google Scholar
Dimitrova, N. & de Lange, T. Cell cycle dependent role of MRN at dysfunctional telomeres: ATM signaling-dependent induction of nonhomologous end joining (NHEJ) in G1 and resection-mediated inhibition of NHEJ in G2. Mol. Cell. Biol.29, 5552–5563 (2009). CASPubMedPubMed Central Google Scholar
Verdun, R. E., Crabbe, L., Haggblom, C. & Karlseder, J. Functional human telomeres are recognized as DNA damage in G2 of the cell cycle. Mol. Cell20, 551–561 (2005). CASPubMed Google Scholar
Potts, P. R. & Yu, H. The SMC5/6 complex maintains telomere length in ALT cancer cells through SUMOylation of telomere-binding proteins. Nature Struct. Mol. Biol.14, 581–590 (2007). This study provided evidence that the SMC5–SMC6 complex of HR proteins is required for ALT activity, and that this is dependent on their ability to sumoylate telomere-binding proteins. CAS Google Scholar
McEachern, M. J. & Haber, J. E. Break-induced replication and recombinational telomere elongation in yeast. Annu. Rev. Biochem.75, 111–135 (2006). CASPubMed Google Scholar
Potts, P. R. The yin and yang of the MMS21–SMC5/6 SUMO ligase complex in homologous recombination. DNA Repair (Amst.)8, 499–506 (2009). CAS Google Scholar
Saharia, A. & Stewart, S. A. FEN1 contributes to telomere stability in ALT-positive tumor cells. Oncogene28, 1162–1167 (2009). CASPubMed Google Scholar
Zeng, S. et al. Telomere recombination requires the MUS81 endonuclease. Nature Cell Biol.11, 616–623 (2009). CASPubMed Google Scholar
Fan, Q., Zhang, F., Barrett, B., Ren, K. & Andreassen, P. R. A role for monoubiquitinated FANCD2 at telomeres in ALT cells. Nucleic Acids Res.37, 1740–1754 (2009). CASPubMedPubMed Central Google Scholar
Crabbe, L., Verdun, R. E., Haggblom, C. I. & Karlseder, J. Defective telomere lagging strand synthesis in cells lacking WRN helicase activity. Science306, 1951–1953 (2004). CASPubMed Google Scholar
Liu, Y., Kao, H. I. & Bambara, R. A. Flap endonuclease 1: a central component of DNA metabolism. Annu. Rev. Biochem.73, 589–615 (2004). CASPubMed Google Scholar
Fasching, C. L., Bower, K. & Reddel, R. R. Telomerase-independent telomere length maintenance in the absence of ALT-associated PML bodies. Cancer Res.65, 2722–2729 (2005). CASPubMed Google Scholar
Marciniak, R. A. et al. A novel telomere structure in human alternative lengthening of telomeres cell line. Cancer Res.65, 2730–2737 (2005). CASPubMed Google Scholar
Ciccia, A., McDonald, N. & West, S. C. Structural and functional relationships of the XPF/MUS81 family of proteins. Annu. Rev. Biochem.77, 259–287 (2008). CASPubMed Google Scholar
Thompson, L. H. & Hinz, J. M. Cellular and molecular consequences of defective Fanconi anemia proteins in replication-coupled DNA repair: mechanistic insights. Mutat. Res.668, 54–72 (2009). CASPubMedPubMed Central Google Scholar
Verdun, R. E. & Karlseder, J. The DNA damage machinery and homologous recombination pathway act consecutively to protect human telomeres. Cell127, 709–720 (2006). CASPubMed Google Scholar
Temime-Smaali, N. et al. Topoisomerase IIIα is required for normal proliferation and telomere stability in alternative lengthening of telomeres. EMBO J.27, 1513–1524 (2008). CASPubMedPubMed Central Google Scholar
van Steensel, B., Smogorzewska, A. & de Lange, T. TRF2 protects human telomeres from end-to-end fusions. Cell92, 401–413 (1998). CASPubMed Google Scholar
Jegou, T. et al. Dynamics of telomeres and PML nuclear bodies in a telomerase negative human cell line. Mol. Biol. Cell20, 2070–2082 (2009). CASPubMedPubMed Central Google Scholar
Murnane, J. P. & Yu, L. C. Acquisition of telomere repeat sequences by transfected DNA integrated at the site of a chromosome break. Mol. Cell. Biol.13, 977–983 (1993). This study showed that healing of broken DNA ends by addition of telomeric DNA can occur in the absence of telomerase. CASPubMedPubMed Central Google Scholar
Johnson, F. B. et al. The Saccharomyces cerevisiae WRN homolog Sgs1p participates in telomere maintenance in cells lacking telomerase. EMBO J.20, 905–913 (2001). CASPubMedPubMed Central Google Scholar
Huang, P. H. et al. SGS1 is required for telomere elongation in the absence of telomerase. Curr. Biol.11, 125–129 (2001). CASPubMed Google Scholar
Laud, P. R. et al. Elevated telomere–telomere recombination in WRN-deficient, telomere dysfunctional cells promotes escape from senescence and engagement of the ALT pathway. Genes Dev.19, 2560–2570 (2005). CASPubMedPubMed Central Google Scholar
Perrem, K. et al. Repression of an alternative mechanism for lengthening of telomeres in somatic cell hybrids. Oncogene18, 3383–3390 (1999). CASPubMed Google Scholar
Palm, W., Hockemeyer, D., Kibe, T. & de Lange, T. Functional dissection of human and mouse POT1 proteins. Mol. Cell. Biol.29, 471–482 (2009). CASPubMed Google Scholar
Celli, G. B., Denchi, E. L. & de Lange, T. Ku70 stimulates fusion of dysfunctional telomeres yet protects chromosome ends from homologous recombination. Nature Cell Biol.8, 885–890 (2006). PubMed Google Scholar
Wu, L. et al. Pot1 deficiency initiates DNA damage checkpoint activation and aberrant homologous recombination at telomeres. Cell126, 49–62 (2006). CASPubMed Google Scholar
He, H. et al. POT1b protects telomeres from end-to-end chromosomal fusions and aberrant homologous recombination. EMBO J.25, 5180–5190 (2006). CASPubMedPubMed Central Google Scholar
Stansel, R. M., Subramanian, D. & Griffith, J. D. p53 binds telomeric single strand overhangs and t-loop junctions in vitro. J. Biol. Chem.277, 11625–11628 (2002). CASPubMed Google Scholar
Fouche, N. et al. The basic domain of TRF2 directs binding to DNA junctions irrespective of the presence of TTAGGG repeats. J. Biol. Chem.281, 37486–37495 (2006). CASPubMed Google Scholar
Arnoult, N., Saintome, C., Ourliac-Garnier, I., Riou, J. F. & Londono-Vallejo, A. Human POT1 is required for efficient telomere C-rich strand replication in the absence of WRN. Genes Dev.23, 2915–2924 (2009). CASPubMedPubMed Central Google Scholar
Cesare, A. J. et al. Spontaneous occurrence of telomeric DNA damage response in the absence of chromosome fusions. Nature Struct. Mol. Biol.16, 1244–1251 (2009). Previous studies of mutant telomere-binding proteins had shown that telomeres can adopt one or more states in which they elicit a DDR but still protect against chromosome end joining. This study showed that telomeres in such a state occur commonly in ALT cells, and that this phenotype is partially rescued by overexpression of TRF2, provided that functional ATM is present. CAS Google Scholar
Blasco, M. A. The epigenetic regulation of mammalian telomeres. Nature Rev. Genet.8, 299–309 (2007). CASPubMed Google Scholar
Vera, E., Canela, A., Fraga, M. F., Esteller, M. & Blasco, M. A. Epigenetic regulation of telomeres in human cancer. Oncogene27, 6817–6833 (2008). CASPubMed Google Scholar
Ng, L. J., Cropley, J. E., Pickett, H. A., Reddel, R. R. & Suter, C. M. Telomerase activity is associated with an increase in DNA methylation at the proximal subtelomere and a reduction in telomeric transcription. Nucleic Acids Res.37, 1152–1159 (2009). CASPubMedPubMed Central Google Scholar
Tilman, G. et al. Subtelomeric DNA hypomethylation is not required for telomeric sister chromatid exchanges in ALT cells. Oncogene28, 1682–1693 (2009). CASPubMed Google Scholar
Takai, H., Smogorzewska, A. & de Lange, T. DNA damage foci at dysfunctional telomeres. Curr. Biol.13, 1549–1556 (2003). CASPubMed Google Scholar
Counter, C. M. et al. Telomere shortening associated with chromosome instability is arrested in immortal cells which express telomerase activity. EMBO J.11, 1921–1929 (1992). CASPubMedPubMed Central Google Scholar
Smogorzewska, A., Karlseder, J., Holtgreve-Grez, H., Jauch, A. & de Lange, T. DNA ligase IV-dependent NHEJ of deprotected mammalian telomeres in G1 and G2. Curr. Biol.12, 1635–1644 (2002). CASPubMed Google Scholar
Bae, N. S. & Baumann, P. A RAP1/TRF2 complex inhibits nonhomologous end-joining at human telomeric DNA ends. Mol. Cell26, 323–334 (2007). CASPubMed Google Scholar
Sarthy, J., Bae, N. S., Scrafford, J. & Baumann, P. Human RAP1 inhibits non-homologous end joining at telomeres. EMBO J.28, 3390–3399 (2009). CASPubMedPubMed Central Google Scholar
Chin, L. et al. p53 deficiency rescues the adverse effects of telomere loss and cooperates with telomere dysfunction to accelerate carcinogenesis. Cell97, 527–538 (1999). CASPubMed Google Scholar
Smogorzewska, A. & de Lange, T. Different telomere damage signaling pathways in human and mouse cells. EMBO J.21, 4338–4348 (2002). CASPubMedPubMed Central Google Scholar
Cesare, A. J. & Reddel, R. R. Telomere uncapping and alternative lengthening of telomeres. Mech. Ageing Dev.129, 99–108 (2008). CASPubMed Google Scholar
Karlseder, J. et al. The telomeric protein TRF2 binds the ATM kinase and can inhibit the ATM-dependent DNA damage response. PLoS Biol.2, e240 (2004). PubMedPubMed Central Google Scholar
Denchi, E. L. & de Lange, T. Protection of telomeres through independent control of ATM and ATR by TRF2 and POT1. Nature448, 1068–1071 (2007). CASPubMed Google Scholar
Bernardi, R. & Pandolfi, P. P. Structure, dynamics and functions of promyelocytic leukaemia nuclear bodies. Nature Rev. Mol. Cell Biol.8, 1006–1016 (2007). CAS Google Scholar
Molenaar, C. et al. Visualizing telomere dynamics in living mammalian cells using PNA probes. EMBO J.22, 6631–6641 (2003). CASPubMedPubMed Central Google Scholar
Fasching, C. L., Neumann, A. A., Muntoni, A., Yeager, T. R. & Reddel, R. R. DNA damage induces alternative lengthening of telomeres (ALT) associated promyelocytic leukemia bodies that preferentially associate with linear telomeric DNA. Cancer Res.67, 7072–7077 (2007). CASPubMed Google Scholar
Cerone, M. A., Autexier, C., Londono-Vallejo, J. A. & Bacchetti, S. A human cell line that maintains telomeres in the absence of telomerase and of key markers of ALT. Oncogene24, 7893–7901 (2005). CASPubMed Google Scholar
Jiang, W. Q. et al. Induction of alternative lengthening of telomeres-associated PML bodies by p53/p21 requires HP1 proteins. J. Cell Biol.185, 797–810 (2009). CASPubMedPubMed Central Google Scholar
Jiang, W. Q. & Ringertz, N. Altered distribution of the promyelocytic leukemia-associated protein is associated with cellular senescence. Cell Growth Differ.8, 513–522 (1997). CASPubMed Google Scholar
Jiang, W. Q., Zhong, Z. H., Henson, J. D. & Reddel, R. R. Identification of candidate alternative lengthening of telomeres genes by methionine restriction and RNA interference. Oncogene26, 4635–4647 (2007). CASPubMed Google Scholar
Wu, G., Lee, W. H. & Chen, P. L. NBS1 and TRF1 colocalize at promyelocytic leukemia bodies during late S/G2 phases in immortalized telomerase-negative cells. Implication of NBS1 in alternative lengthening of telomeres. J. Biol. Chem.275, 30618–30622 (2000). CASPubMed Google Scholar
Nabetani, A., Yokoyama, O. & Ishikawa, F. Localization of hRad9, hHus1, hRad1 and hRad17, and caffeine-sensitive DNA replication at ALT (alternative lengthening of telomeres)-associated promyelocytic leukemia body. J. Biol. Chem.279, 25849–25857 (2004). CASPubMed Google Scholar
Grobelny, J. V., Godwin, A. K. & Broccoli, D. ALT-associated PML bodies are present in viable cells and are enriched in cells in the G2/M phase of the cell cycle. J. Cell Sci.113, 4577–4585 (2000). CASPubMed Google Scholar
Draskovic, I. et al. Probing PML body function in ALT cells reveals spatiotemporal requirements for telomere recombination. Proc. Natl Acad. Sci. USA106, 15726–15731 (2009). CASPubMedPubMed Central Google Scholar